Resulting from PD-L1 positive linked with shorter survival events considering various epithelial-originated cancers, various studies tended to treat it as a novel prognostic marker.[45] However, there also appeared conflicting result unsurprisingly.[46,47] The exact mechanism between immune microenvironment and tumor was undefined as we know. The gene discussed is CD274; the disease is cancer.